rs1555796197
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_003072.5(SMARCA4):c.4781A>G(p.Lys1594Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4877A>G | p.Lys1626Arg | missense_variant | Exon 35 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4781A>G | p.Lys1594Arg | missense_variant | Exon 34 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4877A>G | p.Lys1626Arg | missense_variant | Exon 35 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4781A>G | p.Lys1594Arg | missense_variant | Exon 34 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4787A>G | p.Lys1596Arg | missense_variant | Exon 34 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4691A>G | p.Lys1564Arg | missense_variant | Exon 34 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4691A>G | p.Lys1564Arg | missense_variant | Exon 33 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4691A>G | p.Lys1564Arg | missense_variant | Exon 33 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4688A>G | p.Lys1563Arg | missense_variant | Exon 34 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4202A>G | p.Lys1401Arg | missense_variant | Exon 31 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3431A>G | p.Lys1144Arg | missense_variant | Exon 27 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3413A>G | p.Lys1138Arg | missense_variant | Exon 26 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3275A>G | p.Lys1092Arg | missense_variant | Exon 26 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.3041A>G | p.Lys1014Arg | missense_variant | Exon 24 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.845A>G | p.Lys282Arg | missense_variant | Exon 7 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1408350Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 695684
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces lysine with arginine at codon 1626 of the SMARCA4 protein (p.Lys1626Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 537809). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Rhabdoid tumor predisposition syndrome 2;C3553249:Intellectual disability, autosomal dominant 16 Other:1
Variant interpreted as Uncertain significance and reported on 11-30-2017 by Lab Invitae. This variant was reported as possibly mosaic in this individual. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at